Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 489

1.

NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.

Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S, Leiter E, Hesselton R, Wagar EJ, Leif JH, Kollet O, Lapidot T, Greiner DL.

J Immunol. 2000 Mar 1;164(5):2496-507.

2.

Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.

Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, et al.

J Immunol. 1995 Jan 1;154(1):180-91.

PMID:
7995938
3.

NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment.

Shultz LD, Banuelos S, Lyons B, Samuels R, Burzenski L, Gott B, Lang P, Leif J, Appel M, Rossini A, Greiner DL.

Transplantation. 2003 Oct 15;76(7):1036-42.

PMID:
14557749
4.

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.

Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R.

J Immunol. 2005 May 15;174(10):6477-89.

5.

Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.

Wagar EJ, Cromwell MA, Shultz LD, Woda BA, Sullivan JL, Hesselton RM, Greiner DL.

J Immunol. 2000 Jul 1;165(1):518-27.

6.

Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.

Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB, Rajan TV, Gott B, Roopenian DC, Shultz LD.

J Immunol. 1997 Apr 15;158(8):3578-86.

PMID:
9103418
7.

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T.

Blood. 2002 Nov 1;100(9):3175-82.

9.

Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.

Lowry PA, Shultz LD, Greiner DL, Hesselton RM, Kittler EL, Tiarks CY, Rao SS, Reilly J, Leif JH, Ramshaw H, Stewart FM, Quesenberry PJ.

Biol Blood Marrow Transplant. 1996 Feb;2(1):15-23.

PMID:
9078350
10.
11.

Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.

Christianson SW, Greiner DL, Schweitzer IB, Gott B, Beamer GL, Schweitzer PA, Hesselton RM, Shultz LD.

Cell Immunol. 1996 Aug 1;171(2):186-99.

PMID:
8806787
12.

Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.

Berney T, Molano RD, Pileggi A, Cattan P, Li H, Ricordi C, Inverardi L.

Transplantation. 2001 Jul 15;72(1):133-40.

PMID:
11468548
13.

Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.

Yoshino H, Ueda T, Kawahata M, Kobayashi K, Ebihara Y, Manabe A, Tanaka R, Ito M, Asano S, Nakahata T, Tsuji K.

Bone Marrow Transplant. 2000 Dec;26(11):1211-6.

14.

Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.

Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, Dewan MZ, Yu Z, Ito M, Morio T, Shimizu N, Honda M, Yamamoto N.

Blood. 2007 Jan 1;109(1):212-8. Epub 2006 Sep 5.

15.

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain.

Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, Thrasher AJ.

Br J Haematol. 1998 Nov;103(2):335-42.

PMID:
9827902
16.

An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice.

Minamiguchi H, Wingard JR, Laver JH, Mainali ES, Shultz LD, Ogawa M.

Biol Blood Marrow Transplant. 2005 Jul;11(7):487-94.

17.
18.

Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.

Camacho RE, Wnek R, Fischer P, Shah K, Zaller DM, Woods A, La Monica N, Aurisicchio L, Fitzgerald-Bocarsly P, Koo GC.

Exp Hematol. 2007 Aug;35(8):1219-30.

PMID:
17662890
19.

Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.

Rice AM, Wood JA, Milross CG, Collins CJ, McCarthy NF, Vowels MR.

Transplantation. 2000 Mar 15;69(5):927-35.

PMID:
10755552
20.

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M.

Blood. 2005 Sep 1;106(5):1565-73. Epub 2005 May 26.

Supplemental Content

Support Center